Ma J. 1 Clinical Efficacy and Serum Inflammatory Factor Level (serum IFCs, bone Gla protein (BGP), and bone turnover markers β-collagen degradation product (β-CTX), and procollagen type 1 N-terminal propeptide (P1NP) )Changes of Zoledronic Acid and Denosumab in T: serum IFCs, bone Gla protein (BGP), and bone turnover markers β-collagen degradation product (β-CTX), and procollagen type 1 N-terminal propeptide (P1NP) ). J Med Biochem [Internet]. 2025 Feb. 24 [cited 2026 Jul. 12];44(3):587-94. Available from: https://asistent.ceon.rs/index.php/jomb/article/view/51444